 | • レポートコード：MRC2-11QY03905 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はナルコレプシーのグローバル市場について調査・分析したレポートです。種類別（睡眠ポリグラフ検査、睡眠潜時反復検査）市場規模、用途別（病院、診療所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ナルコレプシーの競争状況、市場シェア ・世界のナルコレプシー市場：種類別市場規模 2015年-2020年（睡眠ポリグラフ検査、睡眠潜時反復検査） ・世界のナルコレプシー市場：種類別市場規模予測 2021年-2026年（睡眠ポリグラフ検査、睡眠潜時反復検査） ・世界のナルコレプシー市場：用途別市場規模 2015年-2020年（病院、診療所、小売薬局） ・世界のナルコレプシー市場：用途別市場規模予測 2021年-2026年（病院、診療所、小売薬局） ・北米のナルコレプシー市場分析：米国、カナダ ・ヨーロッパのナルコレプシー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのナルコレプシー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のナルコレプシー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのナルコレプシー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Jazz Pharmaceuticals、Bioprojet、Arena Pharmaceuticals、Graymark Healthcare、Mylan、Teva Pharmaceutical Industries、Novartis、Takeda、Shionogi、Ligand Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
Market Analysis and Insights: Global Narcolepsy Market
The global Narcolepsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Narcolepsy Scope and Market Size
Narcolepsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Jazz Pharmaceuticals
Bioprojet
Arena Pharmaceuticals
Graymark Healthcare
Mylan
Teva Pharmaceutical Industries
Novartis
Takeda
Shionogi
Ligand Pharmaceuticals
Market segment by Type, the product can be split into
Polysomnogram
Multiple Sleep Latency Test
Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Narcolepsy Revenue
1.4 Market by Type
1.4.1 Global Narcolepsy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Polysomnogram
1.4.3 Multiple Sleep Latency Test
1.5 Market by Application
1.5.1 Global Narcolepsy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Market Perspective (2015-2026)
2.2 Global Narcolepsy Growth Trends by Regions
2.2.1 Narcolepsy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Narcolepsy Historic Market Share by Regions (2015-2020)
2.2.3 Narcolepsy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Narcolepsy Market Growth Strategy
2.3.6 Primary Interviews with Key Narcolepsy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Players by Market Size
3.1.1 Global Top Narcolepsy Players by Revenue (2015-2020)
3.1.2 Global Narcolepsy Revenue Market Share by Players (2015-2020)
3.1.3 Global Narcolepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Narcolepsy Market Concentration Ratio
3.2.1 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Narcolepsy Revenue in 2019
3.3 Narcolepsy Key Players Head office and Area Served
3.4 Key Players Narcolepsy Product Solution and Service
3.5 Date of Enter into Narcolepsy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Narcolepsy Historic Market Size by Type (2015-2020)
4.2 Global Narcolepsy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Narcolepsy Market Size by Application (2015-2020)
5.2 Global Narcolepsy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Narcolepsy Market Size (2015-2020)
6.2 Narcolepsy Key Players in North America (2019-2020)
6.3 North America Narcolepsy Market Size by Type (2015-2020)
6.4 North America Narcolepsy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Narcolepsy Market Size (2015-2020)
7.2 Narcolepsy Key Players in Europe (2019-2020)
7.3 Europe Narcolepsy Market Size by Type (2015-2020)
7.4 Europe Narcolepsy Market Size by Application (2015-2020)
8 China
8.1 China Narcolepsy Market Size (2015-2020)
8.2 Narcolepsy Key Players in China (2019-2020)
8.3 China Narcolepsy Market Size by Type (2015-2020)
8.4 China Narcolepsy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Narcolepsy Market Size (2015-2020)
9.2 Narcolepsy Key Players in Japan (2019-2020)
9.3 Japan Narcolepsy Market Size by Type (2015-2020)
9.4 Japan Narcolepsy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Narcolepsy Market Size (2015-2020)
10.2 Narcolepsy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Narcolepsy Market Size by Type (2015-2020)
10.4 Southeast Asia Narcolepsy Market Size by Application (2015-2020)
11 India
11.1 India Narcolepsy Market Size (2015-2020)
11.2 Narcolepsy Key Players in India (2019-2020)
11.3 India Narcolepsy Market Size by Type (2015-2020)
11.4 India Narcolepsy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Narcolepsy Market Size (2015-2020)
12.2 Narcolepsy Key Players in Central & South America (2019-2020)
12.3 Central & South America Narcolepsy Market Size by Type (2015-2020)
12.4 Central & South America Narcolepsy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Jazz Pharmaceuticals
13.1.1 Jazz Pharmaceuticals Company Details
13.1.2 Jazz Pharmaceuticals Business Overview
13.1.3 Jazz Pharmaceuticals Narcolepsy Introduction
13.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2015-2020))
13.1.5 Jazz Pharmaceuticals Recent Development
13.2 Bioprojet
13.2.1 Bioprojet Company Details
13.2.2 Bioprojet Business Overview
13.2.3 Bioprojet Narcolepsy Introduction
13.2.4 Bioprojet Revenue in Narcolepsy Business (2015-2020)
13.2.5 Bioprojet Recent Development
13.3 Arena Pharmaceuticals
13.3.1 Arena Pharmaceuticals Company Details
13.3.2 Arena Pharmaceuticals Business Overview
13.3.3 Arena Pharmaceuticals Narcolepsy Introduction
13.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2015-2020)
13.3.5 Arena Pharmaceuticals Recent Development
13.4 Graymark Healthcare
13.4.1 Graymark Healthcare Company Details
13.4.2 Graymark Healthcare Business Overview
13.4.3 Graymark Healthcare Narcolepsy Introduction
13.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2015-2020)
13.4.5 Graymark Healthcare Recent Development
13.5 Mylan
13.5.1 Mylan Company Details
13.5.2 Mylan Business Overview
13.5.3 Mylan Narcolepsy Introduction
13.5.4 Mylan Revenue in Narcolepsy Business (2015-2020)
13.5.5 Mylan Recent Development
13.6 Teva Pharmaceutical Industries
13.6.1 Teva Pharmaceutical Industries Company Details
13.6.2 Teva Pharmaceutical Industries Business Overview
13.6.3 Teva Pharmaceutical Industries Narcolepsy Introduction
13.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2015-2020)
13.6.5 Teva Pharmaceutical Industries Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Narcolepsy Introduction
13.7.4 Novartis Revenue in Narcolepsy Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Takeda
13.8.1 Takeda Company Details
13.8.2 Takeda Business Overview
13.8.3 Takeda Narcolepsy Introduction
13.8.4 Takeda Revenue in Narcolepsy Business (2015-2020)
13.8.5 Takeda Recent Development
13.9 Shionogi
13.9.1 Shionogi Company Details
13.9.2 Shionogi Business Overview
13.9.3 Shionogi Narcolepsy Introduction
13.9.4 Shionogi Revenue in Narcolepsy Business (2015-2020)
13.9.5 Shionogi Recent Development
13.10 Ligand Pharmaceuticals
13.10.1 Ligand Pharmaceuticals Company Details
13.10.2 Ligand Pharmaceuticals Business Overview
13.10.3 Ligand Pharmaceuticals Narcolepsy Introduction
13.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2015-2020)
13.10.5 Ligand Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Narcolepsy Key Market Segments
Table 2. Key Players Covered: Ranking by Narcolepsy Revenue
Table 3. Ranking of Global Top Narcolepsy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Narcolepsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Polysomnogram
Table 6. Key Players of Multiple Sleep Latency Test
Table 7. Global Narcolepsy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Narcolepsy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Narcolepsy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Narcolepsy Market Share by Regions (2015-2020)
Table 11. Global Narcolepsy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Narcolepsy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Narcolepsy Market Growth Strategy
Table 17. Main Points Interviewed from Key Narcolepsy Players
Table 18. Global Narcolepsy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Narcolepsy Market Share by Players (2015-2020)
Table 20. Global Top Narcolepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy as of 2019)
Table 21. Global Narcolepsy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Narcolepsy Product Solution and Service
Table 24. Date of Enter into Narcolepsy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Narcolepsy Market Size Share by Type (2015-2020)
Table 28. Global Narcolepsy Revenue Market Share by Type (2021-2026)
Table 29. Global Narcolepsy Market Size Share by Application (2015-2020)
Table 30. Global Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Narcolepsy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Narcolepsy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Narcolepsy Market Share (2019-2020)
Table 34. North America Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Narcolepsy Market Share by Type (2015-2020)
Table 36. North America Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Narcolepsy Market Share by Application (2015-2020)
Table 38. Europe Key Players Narcolepsy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Narcolepsy Market Share (2019-2020)
Table 40. Europe Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Narcolepsy Market Share by Type (2015-2020)
Table 42. Europe Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Narcolepsy Market Share by Application (2015-2020)
Table 44. China Key Players Narcolepsy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Narcolepsy Market Share (2019-2020)
Table 46. China Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 47. China Narcolepsy Market Share by Type (2015-2020)
Table 48. China Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 49. China Narcolepsy Market Share by Application (2015-2020)
Table 50. Japan Key Players Narcolepsy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Narcolepsy Market Share (2019-2020)
Table 52. Japan Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Narcolepsy Market Share by Type (2015-2020)
Table 54. Japan Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Narcolepsy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Narcolepsy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Narcolepsy Market Share (2019-2020)
Table 58. Southeast Asia Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Narcolepsy Market Share by Type (2015-2020)
Table 60. Southeast Asia Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Narcolepsy Market Share by Application (2015-2020)
Table 62. India Key Players Narcolepsy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Narcolepsy Market Share (2019-2020)
Table 64. India Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 65. India Narcolepsy Market Share by Type (2015-2020)
Table 66. India Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 67. India Narcolepsy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Narcolepsy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Narcolepsy Market Share (2019-2020)
Table 70. Central & South America Narcolepsy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Narcolepsy Market Share by Type (2015-2020)
Table 72. Central & South America Narcolepsy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Narcolepsy Market Share by Application (2015-2020)
Table 74. Jazz Pharmaceuticals Company Details
Table 75. Jazz Pharmaceuticals Business Overview
Table 76. Jazz Pharmaceuticals Product
Table 77. Jazz Pharmaceuticals Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 78. Jazz Pharmaceuticals Recent Development
Table 79. Bioprojet Company Details
Table 80. Bioprojet Business Overview
Table 81. Bioprojet Product
Table 82. Bioprojet Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 83. Bioprojet Recent Development
Table 84. Arena Pharmaceuticals Company Details
Table 85. Arena Pharmaceuticals Business Overview
Table 86. Arena Pharmaceuticals Product
Table 87. Arena Pharmaceuticals Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 88. Arena Pharmaceuticals Recent Development
Table 89. Graymark Healthcare Company Details
Table 90. Graymark Healthcare Business Overview
Table 91. Graymark Healthcare Product
Table 92. Graymark Healthcare Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 93. Graymark Healthcare Recent Development
Table 94. Mylan Company Details
Table 95. Mylan Business Overview
Table 96. Mylan Product
Table 97. Mylan Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 98. Mylan Recent Development
Table 99. Teva Pharmaceutical Industries Company Details
Table 100. Teva Pharmaceutical Industries Business Overview
Table 101. Teva Pharmaceutical Industries Product
Table 102. Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 103. Teva Pharmaceutical Industries Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. Takeda Business Overview
Table 110. Takeda Product
Table 111. Takeda Company Details
Table 112. Takeda Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 113. Takeda Recent Development
Table 114. Shionogi Company Details
Table 115. Shionogi Business Overview
Table 116. Shionogi Product
Table 117. Shionogi Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 118. Shionogi Recent Development
Table 119. Ligand Pharmaceuticals Company Details
Table 120. Ligand Pharmaceuticals Business Overview
Table 121. Ligand Pharmaceuticals Product
Table 122. Ligand Pharmaceuticals Revenue in Narcolepsy Business (2015-2020) (Million US$)
Table 123. Ligand Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Market Share by Type: 2020 VS 2026
Figure 2. Polysomnogram Features
Figure 3. Multiple Sleep Latency Test Features
Figure 4. Global Narcolepsy Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Narcolepsy Report Years Considered
Figure 9. Global Narcolepsy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Narcolepsy Market Share by Regions: 2020 VS 2026
Figure 11. Global Narcolepsy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Narcolepsy Market Share by Players in 2019
Figure 14. Global Top Narcolepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Narcolepsy Revenue in 2019
Figure 16. North America Narcolepsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Narcolepsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Narcolepsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Narcolepsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Narcolepsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Narcolepsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Narcolepsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
ナルコレプシー治療の世界市場（～2026年） Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep. By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimu…- ナルコレプシー治療薬の世界市場（～2026年） Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time. Market Analysis and Insights: Global Narcolepsy Therapeutics Mark…
- 睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …
- 多発性硬化症治療薬の世界市場（～2026年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
- 睡眠検査サービスの世界市場（～2026年） Sleep testing is a diagnostic test that helps determine whether you have obstructive sleep apnea. The sleep testing services market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global…